Advertisement
Advertisement
U.S. markets close in 5 hours 5 minutes
Advertisement
Advertisement
Advertisement
Advertisement

Jeffs' Brands Ltd (JFBR)

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
0.4320+0.0160 (+3.85%)
As of 10:48AM EDT. Market open.
Advertisement
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Bullishpattern detected
Momentum

Momentum

Performance Outlook
Previous Close0.4160
Open0.4401
Bid0.4166 x 800
Ask0.4800 x 1200
Day's Range0.4260 - 0.4320
52 Week Range0.4100 - 2.3600
Volume400
Avg. Volume49,787
Market Cap3.595M
Beta (5Y Monthly)N/A
PE Ratio (TTM)N/A
EPS (TTM)N/A
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
XX.XX
Overvalued

Subscribe to Yahoo Finance Plus to view Fair Value for JFBR

View details
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
  • Jeffs' Brands Ltd
    Analyst Report: Eli Lilly and CompanyEli Lilly is a drug firm with a focus on neuroscience, cardiometabolic, cancer, and immunology. Lilly's key products include Verzenio for cancer; Mounjaro, Jardiance, Trulicity, Humalog, and Humulin for diabetes; and Taltz and Olumiant for immunology.
    Rating
    Fair Value
    Economic Moat
    26 days agoMorningstar
View more
  • GlobeNewswire

    Jeffs’ Brands to Acquire 50.01% Interest in an AI marketing Business to Enhance Its Machine Learning Capabilities

    The Company has entered into a non-binding letter of intent for, among others, the integration of the AI-based tool developed by B24Chat which will strengthen Jeffs' Brands' in-house marketing system and upgrade its marketing and services performance. Tel Aviv, Israel, July 06, 2023 (GLOBE NEWSWIRE) -- Jeffs' Brands Ltd (“Jeffs’ Brands” or the “Company”) (Nasdaq: JFBR, JFBRW), a data-driven e-commerce company operating on the Amazon Marketplace, today announced that it has entered into a non-bin

  • GlobeNewswire

    Rising Demand for Jeffs’ Brands Top Selling Pesticide Brand Spurs Expansion into the Wholesale Market

    The Fort Brand's sales from the beginning of 2023 amounted to over $3.1 million in the U.K. alone, selling on the Amazon Marketplace U.K., eBay and other online platforms Tel Aviv, Israel, June 16, 2023 (GLOBE NEWSWIRE) -- Jeffs' Brands Ltd (“Jeffs’ Brands” or the “Company”) (Nasdaq: JFBR, JFBRW), a data-driven e-commerce company operating on the Amazon Marketplace, today announced that it has launched new wholesale channel targeting potential organizations and institutional clients, following a

  • GlobeNewswire

    Jeffs' Brands: SciSparc Nutraceuticals was Granted an Exclusive License for the Sales of CannAmide™ on the Amazon Marketplace in Canada

    Tel Aviv, Israel, June 07, 2023 (GLOBE NEWSWIRE) -- Jeffs' Brands Ltd (the “Company” or “Jeffs' Brands”) (Nasdaq: JFBR), a data-driven e-commerce company operating on the Amazon Marketplace, today announced that SciSparc Nutraceuticals Inc. ("SciSparc Nutraceuticals"), in which the Company owns a 49% equity interest, has entered into an exclusive license and distribution agreement to sell and market CannAmide™ on the Amazon.com marketplace in Canada (“License Agreement”). The exclusive license w

Advertisement
Advertisement